Get 20% lifetime commission for referring investors to digrin.com
here.
AgeX Therapeutics, Inc. (AGE) Financials
Stock symbol AGE is outdated, potentially delisted? Maybe it is available on other exchange?
AGE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 12.2 million | 39.9 million |
| June 30, 2023 | 12.3 million | 34.6 million |
| March 31, 2023 | 12.5 million | 32.5 million |
| Dec. 31, 2022 | 3.2 million | 20.6 million |
AGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -1.9 million | 40000 |
| June 30, 2023 | -2.0 million | 35000 |
| March 31, 2023 | -1.9 million | 70000 |
| Dec. 31, 2022 | -1.3 million | 114000 |
AGE Net Income
No data available :(
AGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 397000 | - | - |
| June 30, 2023 | 261000 | 10.1 million | - |
| March 31, 2023 | 280000 | 10.0 million | - |
| Dec. 31, 2022 | 645000 | 10.5 million | - |
AGE Shares Outstanding
AGE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 218000 | 2.2 million | - |
| June 30, 2023 | - | 160000 | 1.7 million | - |
| March 31, 2023 | - | 174000 | 2.0 million | - |
| Dec. 31, 2022 | - | 208000 | 1.6 million | - |
AGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 46000 | 33000 |
| June 30, 2023 | 9000 | 5000 |
| March 31, 2023 | 10000 | 1000 |
| Dec. 31, 2022 | 8000 | 1000 |
AGE
Price: $11.10
52 week price:
Earnings Per Share: -0.38 USD
P/E Ratio: -1.02
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 785
Market Capitalization: 33.2 million